Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer(ACTS-GC)
Phase 3
- Conditions
- Gastric cancer
- Registration Number
- JPRN-jRCT1080220047
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with Stage II (except T1), IIIA or IIIB gastric cancer who received a surgery of curative resection (curability A or B).
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy and safety
- Secondary Outcome Measures
Name Time Method